Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, ...
The U.S. Environmental Protection Agency on Monday banned the use of two ubiquitous cancer-causing solvents that activists have been targeting for decades.
Nanobiotix's American depositary receipts climbed after the company completed the Phase 1 study of its pancreatic cancer treatment. The stock was up 18% at $3.55 in premarket trading. Shares had ...
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further evaluation in a randomized trial23 months median Overall Survival from date of ...
MIAMI ( WFOR) -- Not long ago, a Stage 4 pancreatic cancer diagnosis was considered a death sentence. But survival rates are improving and one Miami man is living proof! Manny Garcia has a second ...